David Giljohann, CEO of IIN-startup Exicure, discusses SNAs and immunotherapy: “the new new in modern medical miracles.”

EVANSTON, Ill.—David Giljohann, Northwestern professor, former Ryan Fellow, and CEO of IIN-startup Exicure, discusses spherical nucleic acids (SNAs) and immunotherapy, “the new new in modern medical miracles,” on the John Batchelor Show.

https://audioboom.com/posts/7044936-immunotherapies-are-the-new-new-in-modern-medical-miracles-david-giljohann-ceo-exicure-xcur?utm_campaign=detailpage&utm_content=retweet&utm_medium=social&utm_source=twitter

The International Institute for Nanotechnology at Northwestern University is an umbrella organization that represents and unites more than $1 billion in nanotechnology research, education and supporting infrastructure.